3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Non functioning pancreatic endocrine tumor
1
Adenoma, Islet Cell
1
Interventions
Everolimus
5
Temozolomide
4
sargramostim
2
montanide ISA 51
2
lutetium Lu 177 dotatate
2
incomplete Freund's adjuvant
2
Sunitinib
2
Specimen Handling
2
Sorafenib
2
Octreotide
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Fluorouracil
2
Cytoreduction Surgical Procedures
2
Colony-Stimulating Factors
2
Bevacizumab
2
surufatinib
1
recombinant interferon alpha 2b-like protein
1
pentetreotide
1
pasireotide
1
nimotuzumab
1
ibrutinib
1
ganitumab
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
cabozantinib
1
atezolizumab
1
abemaciclib
1
Wound Healing
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenoma, Islet Cell
×
Chromogranin A
×
Clear all
NCT02759718
2016-05-03
CgA
Asan Medical Center
Phase 4
Unknown
111 enrolled